Vitamin D and Chronic Kidney Disease

Authors

  • S.V. Kushnirenko Department of Nephrology and Renal Replacement Therapy of National Medical Academy of Postgraduated Education named after P.L. Shupik Kyiv City Children’s Clinical Hospital № 1, Kyiv, Ukraine
  • L.P. Gorbatova Department of Nephrology and Renal Replacement Therapy of National Medical Academy of Postgraduated Education named after P.L. Shupik Kyiv City Children’s Clinical Hospital № 1, Kyiv, Ukraine
  • O.M. Bogoliy Department of Nephrology and Renal Replacement Therapy of National Medical Academy of Postgraduated Education named after P.L. Shupik Kyiv City Children’s Clinical Hospital № 1, Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2307-1257.0.2.2012.176613

Keywords:

vitamin D, chronic kidney disease

Abstract

The results of 25(ОН)D3 level determination in blood serum of 45 patients with I–V stage chronic kidney disease are described in this article. It is shown that sufficient 25(ОН)D3 level is registered with 6.7 % of patients, vitamin D deficiency — in 24.4 % of patients. Vitamin D (< 50 nM/l) deficiency took detected in 68.9 % of patients. High direct correlation (r = 0.76) was found between the levels of 25(ОН)D3 and total protein. Average inverse power connection (r = –0.35) was determined between the levels of PTH and 25(ОН)D3 in the serum, and the level of urinary protein excretion and 25(ОН)D3 (r = –0.46).

Downloads

Download data is not yet available.

References

Михайлова Н.А. Селективный активатор витамин-Д­рецепторов парикальцитол и его место в лечении хронической болезни почек. Обзор литературы // Лечащий врач. — 2011. — № 2. — С. 82-88.

Николаев А.Ю., Милованов Ю.С. Лечение почечной недостаточности. — М.: Медицинское информационное агентство, 2011. — 592 с.

Alvarez J.A., Law S., Coakley K. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double­blind, placebo­controlled trial // Am. J. Clin. Nutr. — 2012. — 96(3). — P. 672-679.

Alvarez J., Wasse H., Tangpriche V. Vitamin D supplementation in pre­dialysis chronic kidney disease: A systematic review // Dermatoendocrinol. — 2012. — 4(2). — P. 118-127.

Brancaccio D., Cozzolino M., Cannella G. et al. Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO Survey on treatment and mortality // Blood. Purif. — 2011. — № 2. — P. 124-132.

Damasiewiez H., Magliano D., Doly R. 25-hydroxyvitamin D levels and chronic kidney disease in the Aus Diab (Australian Diabets, Obesity and Lifestyle) study // BMC Nephrol. — 2012. — Abstract Jul.

De Zeeuw D., Agarwal R., Amdahl M. et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomized controlled trial // Lancet. — 2010. — 376(9752). — С. 1543-1551.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD­MBD) // Kidney International. — 2009. — 76(Suppl. 113). — P. 1-130.

Mazzaferro S., Brancaccio D., Messa P. et al. Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey // J. Nephrol. — 2011. — № 24(2). — P. 225-235.

Navaneethan S.D., Schold S.D., Arrigain S., Jolly S.E. et al. Low 25-hydroxyvitamin D levels and mortality in non-dialysis­dependent CKD // Am. J. Kid. Dys. — 2011. — 58(4).— P. 536-543.

Pilz S., Iodices S., Zittermann A., Grant W.P., Giandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies // Am. J. Kid. Dis. — 2011. — 58(3). — P. 374-382.

Urena-Torres P., Metzger M., Haymann J.P., Karra S.A. et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD // Am. J. Kid. Dis. — 2011. — 58(4). — P. 544­553.

Published

2022-02-15

How to Cite

Kushnirenko, S., Gorbatova, L., & Bogoliy, O. (2022). Vitamin D and Chronic Kidney Disease. KIDNEYS, (2), 37–43. https://doi.org/10.22141/2307-1257.0.2.2012.176613

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 > >>